Approved monoclonal antibodies.
Name | Sponsor | Approval |
---|---|---|
REGEN-COV (casirivimab and imdevimab) | Regeneron | EUA (November 2020) |
Bamlanivimab and etesevimab | Eli Lilly | EUA (February 2021) |
Sotrovimab | GSK and Vir Biotechnology | EUA (May 2021) |
Regdanvimab | Celltrion | EUA in South Korea (February 2021) |